Form D · Biotechnology

Intellicell Biosciences, Inc.

New York, NY · CIK 0001125280

Offering snapshot reported Dec 3, 2012 · SEC filing

Reported sold
$375K
Offering amount: $6M
Investors reported
3
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Oct 1, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$188K$375KOct 16, 2012: $25,000.00Oct 16, 2012Nov 13, 2012: $125,000.00Nov 13, 2012Dec 3, 2012: $375,000.00Dec 3, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$125,000 → $375,000
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 3, 2012Amendment$375,000$250,000vs Nov 13, 20123SEC filing
Nov 13, 2012Amendment$125,000$100,000vs Oct 16, 20122SEC filing
Oct 16, 2012Initial$25,000No comparison1SEC filing
Mar 26, 2012Amendment$2,475,000$435,000vs Feb 23, 201218SEC filing
Feb 23, 2012Initial$2,040,000No comparison13SEC filing
Nov 7, 2011Initial$340,000No comparison3SEC filing

Offering details

Securities
Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$2.5K
Finders' fees
$0
Form D file number
021-185649
Units of common stock and common stock purchase warrants

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aurora Capital LLC37924

Source: Form D, filed Dec 3, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stuart Goldfarb Director
Michael Hershman Director
Myron Holubiak Director
Leonard Mazur Director
Steven A. Victor Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
460 Park Avenue, 17th Floor
New York, NY, 10022